This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. slipped 7.0% to $1.32 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.6% to 26,253.34 and Dow Jones Industrial Average falling 0.8% to 52,380.66.
This was the stock's second consecutive day of losses.
Inovio Pharmaceuticals Inc. closed 55.7% short of its 52-week high of $2.98, which the company achieved on September 9th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 0.8% to $267.08, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. remained unchanged.
Trading volume totaled 2.7 million, compared to the 50-day average of 4.0 million.
Data source: Dow Jones Market Data, FactSet